Top

Surgical Endoscopy

Published in:

01-12-2012

Adipogenic differentiation of adipose tissue-derived human mesenchymal stem cells: effect of gastric bypass surgery

Authors: Jie-Gen Chen, Anna Spagnoli, Alfonso Torquati

Published in: Surgical Endoscopy | Issue 12/2012

Abstract

Background

Adipose tissue dysfunction is an important feature of obesity characterized by enlarged adipocytes and marked changes in secretion of cytokines. These changes result in insulin resistance, chronic vascular inflammation, oxidative stress, and activation of the renin–angiotensin system (RAS), eventually leading to type 2 diabetes, obesity-related hypertension, and cardiovascular disease (CVD). Several trials have shown that bariatric surgery significantly reduces these comorbidities. However, there is a gap in knowledge regarding the mechanisms whereby bariatric surgery reduces the burden of CVD in obese individuals.

Method

Mesenchymal stem cells (MSCs) were isolated from adipose tissue collected from three groups: (1) nonobese control subjects, (2) obese subjects undergoing gastric bypass surgery (GBS), and (3) subjects 1 year or more after GBS. In the study, MSCs were induced to adipogenic differentiation, and RAS-related gene expressions were determined by quantitative polymerase chain reaction. The effect of angiotensin II (Ang II) on adipogenic differentiation of MSCs also was investigated.

Results

Angiotensinogen mRNA levels in MSCs and differentiated adipocytes were significantly higher in the obese group than in the nonobese control subjects. Renin mRNA levels were significantly higher in the obese group MSCs than in the nonobese and post-GBS groups. Angiotensin-converting enzyme mRNA levels were significantly lower in the MSCs derived from the post-GBS group than in the obese and nonobese control subjects. Serum Ang II levels were significantly lower in the post-GBS group (52.1 ± 4.2 pg/ml) than in the nonobese (85.4 ± 12.4 pg/ml) and obese (84.7 ± 10.0 pg/ml) groups. Ang II treatment inhibited adipogenesis of MSCs in a dose-dependent manner. The inhibitory effect of Ang II was mainly abolished by PD123319, a receptor 2 blocker.

Conclusions

The adipogenesis of MSCs is inhibited by Ang II treatment. Obese individuals are characterized by an upregulation of the RAS-related gene expressions in adipose tissue. This upregulation resolves in post-GBS subjects.

Lavie CJ, Milani RV, Ventura HO (2009) Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53:1925–1932PubMedCrossRef

Poulos SP, Hausman DB, Hausman GJ (2010) The development and endocrine functions of adipose tissue. Mol Cell Endocrinol 323:20–34PubMedCrossRef

Hajer GR, van Haeften TW, Visseren FL (2008) Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 29:2959–2971PubMedCrossRef

Paul M, Poyan Mehr A, Kreutz R (2006) Physiology of local renin–angiotensin systems. Physiol Rev 86:747–803PubMedCrossRef

Atlas SA (2007) The renin–angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm 13:9–20PubMed

Thatcher S, Yiannikouris F, Gupte M, Cassis L (2009) The adipose renin–angiotensin system: role in cardiovascular disease. Mol Cell Endocrinol 302:111–117PubMedCrossRef

Goossens GH, Blaak EE, Arner P, Saris WH, van Baak MA (2007) Angiotensin II: a hormone that affects lipid metabolism in adipose tissue. Int J Obes Lond 31:382–384PubMedCrossRef

Skurk T, Hauner H (2004) Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1. Int J Obes Relat Metab Disord 28:1357–1364PubMedCrossRef

Vaughan DE (2011) PAI-1 antagonists: the promise and the peril. Trans Am Clin Climatol Assoc 122:312–325PubMed

10.

Goossens GH, Jocken JW, Blaak EE, Schiffers PM, Saris WH, van Baak MA (2007) Endocrine role of the renin–angiotensin system in human adipose tissue and muscle: effect of beta-adrenergic stimulation. Hypertension 49:542–547PubMedCrossRef

11.

Schorr U, Blaschke K, Turan S, Distler A, Sharma AM (1998) Relationship between angiotensinogen, leptin, and blood pressure levels in young normotensive men. J Hypertens 16:1475–1480PubMedCrossRef

12.

Jandeleit-Dahm KA, Tikellis C, Reid CM, Johnston CI, Cooper ME (2005) Why blockade of the renin–angiotensin system reduces the incidence of new-onset diabetes. J Hypertens 23:463–473PubMedCrossRef

13.

Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC, Sharma AM (2005) Weight loss and the renin–angiotensin–aldosterone system. Hypertension 45:356–362PubMedCrossRef

14.

Torquati A, Wright K, Melvin W, Richards W (2007) Effect of gastric bypass operation on Framingham and actual risk of cardiovascular events in class II to III obesity. J Am Coll Surg 204:776–782 (discussion 782–773)PubMedCrossRef

15.

Heneghan HM, Meron-Eldar S, Brethauer SA, Schauer PR, Young JB (2011) Effect of bariatric surgery on cardiovascular risk profile. Am J Cardiol 108:1499–1507PubMedCrossRef

16.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef

17.

DeLany JP, Floyd ZE, Zvonic S, Smith A, Gravois A, Reiners E, Wu X, Kilroy G, Lefevre M, Gimble JM (2005) Proteomic analysis of primary cultures of human adipose-derived stem cells: modulation by adipogenesis. Mol Cell Proteomics 4:731–740PubMedCrossRef

18.

Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM (2002) Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes 51:1699–1707PubMedCrossRef

19.

Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M, Qi N, Wang J, Avery MA, Kurtz TW (2004) Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 43:993–1002PubMedCrossRef

20.

Lane MD, Tang QQ (2005) From multipotent stem cell to adipocyte. Birth Defects Res A Clin Mol Teratol 73:476–477PubMedCrossRef

21.

Hotamisligil GS, Spiegelman BM (1994) Tumor necrosis factor alpha: a key component of the obesity–diabetes link. Diabetes 43:1271–1278PubMedCrossRef

22.

Danforth E Jr (2000) Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet 26:13PubMedCrossRef

23.

Ravussin E, Smith SR (2002) Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci 967:363–378PubMedCrossRef

24.

Matsushita K, Wu Y, Okamoto Y, Pratt RE, Dzau VJ (2006) Local renin–angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. Hypertension 48:1095–1102PubMedCrossRef

25.

Saint-Marc P, Kozak LP, Ailhaud G, Darimont C, Negrel R (2001) Angiotensin II as a trophic factor of white adipose tissue: stimulation of adipose cell formation. Endocrinology 142:487–492PubMedCrossRef

26.

Rocchini AP (2002) Obesity hypertension. Am J Hypertens 15:50S–52SPubMedCrossRef

27.

Dallal RM, Hatalski A, Trang A, Chernoff A (2011) Longitudinal analysis of cardiovascular parameters after gastric bypass surgery. Surg Obes Relat Dis. doi:10.1016/j.soard.2011.09.020

Title: Adipogenic differentiation of adipose tissue-derived human mesenchymal stem cells: effect of gastric bypass surgery
Authors: Jie-Gen Chen
Anna Spagnoli
Alfonso Torquati
Publication date: 01-12-2012
Publisher: Springer-Verlag
Published in: Surgical Endoscopy / Issue 12/2012
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI: https://doi.org/10.1007/s00464-012-2353-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Adipogenic differentiation of adipose tissue-derived human mesenchymal stem cells: effect of gastric bypass surgery

Abstract

Background

Method

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Method

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 12/2012

Malfunction and failure of robotic systems during general surgical procedures

Magnetically anchored camera and percutaneous instruments maintain triangulation and improve cosmesis compared with single-site and conventional laparoscopic cholecystectomy

Laparoscopic approaches to gastric gastrointestinal stromal tumors: an institutional review of 57 cases

Endoscopic submucosal dissection for early gastric cancer using a cross-counter technique

A comparison of hexaminolevulinate (Hexvix®) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study

Perioperative results of robotic lung lobectomy: summary of the literature